Experience of using montiget in patients with bronchial asthma of moderate to severe course

Abstract

50 patients aged from 35 to 67 years inclusive with the diagnosis of BA were included in the study. The patients were divided into 2 groups by random sampling. Patients of the first group (control group) -25 people received basic therapy with inhaled glucocorticosteroids and long-acting p2-agonists in the form of combined preparation of Seretide 25/250 meg or 25/500 meg 2 times daily. Patients of the second group -25 people received 25/250 or 50/250 meg Seretide twice a day, and also leukotriene receptor inhibitor Montiget in a dose of 10 mg once daily